We are currently importing the latest prescribing data. You may see incomplete data across the site. Please check back in a couple of hours!

Items which should not routinely be prescribed in primary care - amiodarone by all Sub-ICB Locations

Why it matters:

NHS England guidance states:

May be suitable in patients prior and post cardioversion or in specific patients who also have heart failure or left ventricular impairment.

Must be initiated by a specialist and only continued under a shared care arrangement for patients where other treatments cannot be used, have failed or is in line with NICE Guidance CG180.

Where there is an existing cohort of patients taking amiodarone who are not currently under shared care, it is recommended that these patients are reviewed to ensure that prescribing remains safe and appropriate and a shared care arrangement is introduced.

For guidance on when prescribing may be appropriate in some exceptional circumstances, please see the full NHS England guidance document.

Description: Cost of amiodarone per 1000 patients

Performance: Loading...

Explore:

Tagged as: Cost Saving, Cardiovascular system, NHS England - items which should not routinely be prescribed in primary care, NICE, Safety (or browse all measures)

Sub-ICB Locations are ordered by mean percentile over the past six months. Each chart shows the results for the individual Sub-ICB Location, plus deciles across all Sub-ICB Locations in the NHS in England.

View measure for NHS England combined →



Fetching data...

Do you need help with your analysis? Don't forget to check the FAQ page, and get in touch if you have questions.
Feedback